Floatz logo

Procarbazine

Childhood Central Nervous System Germ Cell Tumor

National Cancer Institute (NCI)Small moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Childhood Central Nervous System Germ Cell Tumor cohort.

Asset / SponsorPhaseRating
Irinotecan
National Cancer Institute (NCI)
Phase 2BB
Eloxatin
National Cancer Institute (NCI)
Phase 2BB
Cediranib
National Cancer Institute (NCI)
Phase 1B
FILGRASTIM
City of Hope Medical Center
Phase 1CCC
Romidepsin
City of Hope Medical Center
Phase 1CCC

View all 28 →

Same molecule, other indications

Procarbazine is also rated in:

central nervous system neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
lymphomaDormant
BB
Indicative ·
69 / 100
View asset →
Adult Giant Cell GlioblastomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →